Citigroup restated their sell rating on shares of Afya (NASDAQ:AFYA – Free Report) in a research note issued to investors on Friday, MarketBeat Ratings reports. They currently have a $15.00 price target on the stock, down from their prior price target of $18.00.
A number of other analysts have also recently commented on the stock. JPMorgan Chase & Co. dropped their target price on shares of Afya from $25.00 to $20.50 and set a “neutral” rating on the stock in a report on Friday, January 17th. The Goldman Sachs Group initiated coverage on shares of Afya in a report on Tuesday, December 3rd. They set a “sell” rating and a $16.00 target price on the stock. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company. According to data from MarketBeat, Afya has an average rating of “Hold” and an average price target of $18.00.
View Our Latest Stock Report on Afya
Afya Stock Down 4.1 %
Institutional Investors Weigh In On Afya
A number of institutional investors have recently added to or reduced their stakes in the stock. Van ECK Associates Corp grew its holdings in Afya by 41.9% during the 4th quarter. Van ECK Associates Corp now owns 9,677 shares of the company’s stock valued at $154,000 after buying an additional 2,856 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Afya by 296.9% in the fourth quarter. Blue Trust Inc. now owns 2,072 shares of the company’s stock valued at $35,000 after purchasing an additional 1,550 shares in the last quarter. Lifestyle Asset Management Inc. grew its holdings in shares of Afya by 5.5% in the fourth quarter. Lifestyle Asset Management Inc. now owns 17,682 shares of the company’s stock valued at $281,000 after purchasing an additional 929 shares in the last quarter. Public Employees Retirement System of Ohio purchased a new position in shares of Afya in the third quarter valued at $34,000. Finally, State Street Corp lifted its position in Afya by 118.2% in the third quarter. State Street Corp now owns 73,098 shares of the company’s stock worth $1,248,000 after buying an additional 39,592 shares during the last quarter. 88.02% of the stock is owned by hedge funds and other institutional investors.
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Articles
- Five stocks we like better than Afya
- Are Penny Stocks a Good Fit for Your Portfolio?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Best Stocks Under $10.00
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Dividend Capture Strategy: What You Need to Know
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.